Endometrial cancer: Molecular and therapeutic aspects

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 169, Issue 1, 2013, Pages 1-9

  Tsikouras, Panagiotis ^a   Bouchlariotou, Sofia ^a   Vrachnis, Nikolaos ^b   Dafopoulos, Alexandros ^a   Galazios, Georgios ^a   Csorba, Roland ^c   Von Tempelhoff, Georg Friedrich ^c  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Department of Obstetrics and Gynecology of Clinicum ^*  (Germany)

Author keywords

Endometrial cancer; Management; Molecular biology

Indexed keywords

ANASTROZOLE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GESTAGEN; GONADORELIN AGONIST; HORMONE DERIVATIVE; LETROZOLE; LEVONOGESTREL; LOW MOLECULAR WEIGHT HEPARIN; MAMMALIAN TARGET OF RAPAMYCIN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE; PROGESTERONE RECEPTOR A; PROTEIN KINASE B; PROTEIN P16; PROTEIN P53; TAMOXIFEN; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHEMOSENSITIVITY; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CURETTAGE; EDEMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; EXTERNAL BEAM RADIOTHERAPY; FEMALE FERTILITY; HETEROZYGOSITY LOSS; HUMAN; HYPERGLYCEMIA; HYSTERECTOMY; HYSTEROSCOPY; INTRACELLULAR SIGNALING; LAPAROTOMY; LUNG EMBOLISM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MENSTRUAL CYCLE; METASTASIS; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR GENETICS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVARIAN PRESERVATION; OVARY CANCER; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTMENOPAUSE; PRECANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; REVIEW; SALPINGOOOPHORECTOMY; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); THROMBOEMBOLISM; TUMOR SUPPRESSOR GENE; VAGINA BLEEDING; VENOUS STASIS; VENOUS THROMBOEMBOLISM; WEIGHT GAIN;

EID: 84879091397     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.01.018     Document Type: Review

References (78)

1. L.A.G. Ries, D. Melbert, and M. Krapcho SEER Cancer Statistics Review, 1975-2005 2008 National Cancer Institute Bethesda, MD based on November 2007 SEER data submission posted to the SEER web site http://seer. cancer.gov/csr/1975-2005/
2. A. Doll, M. Abal, and M. Rigau Novel molecular profiles of endometrial cancer-new light through old windows Journal of Steroid Biochemistry and Molecular Biology 108 2008 221 229
3. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecologic Oncology 15 1983 10 17
4. S. Lax, B. Kendall, and H. Tashiro The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways Cancer 88 2000 814 824
5. B. Dobrzycka, S.J. Terlikowski, and A. Mazurek Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer International Journal of Cancer 127 2010 612 621
6. J. Hecht, and G.L. Mutter Molecular and pathologic aspects of endometrial carcinogenesis Journal of Clinical Oncology 24 2006 4783 4791
7. G.L. Mutter PTEN a protean tumor suppressor American Journal of Pathology 158 2001 1895 1898
8. Y.B. Kim, C.H. Holschneider, K. Ghosh, R.K. Nieberg, and F.J. Montz Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review of the literature Cancer 79 1997 320 327
9. G.L. Maxwell, J.I. Risinger, and C. Gumbs Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias Cancer Research 58 1998 2500 2503
10. A. Yeramian, G. Moreno-Bueno, and X. Dolcet Endometrial carcinoma: molecular alterations involved in tumor development and progression Oncogene 19 2012 10.1038/onc.2012.76
11. K. Oda, D. Stokoe, Y. Taketani, and F. McCormick High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma Cancer Research 65 2005 10669 10673
12. G.L. Mutter, K.A. Boynton, W.C. Faquin, R.E. Ruiz, and A.S. Jovanovic Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer Cancer Research 56 1996 4483 4486
13. S. Lax Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification Virchows Archiv 444 2004 213 223
14. G.E. Konecny, L. Santos, and B. Winterhoff HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer British Journal of Cancer 100 2009 89 95
15. T. Susini, G. Amunni, and C. Molino Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called "low-risk" patients with well and moderately differentiated tumors Cancer 109 2007 882 890
16. K. Ito, H. Utsunomiya, and N. Yaegashi Biological roles of estrogen and progesterone in human endometrial carcinomanew developments in potential endocrine therapy for endometrial cancer Endocrine Journal 54 2007 667 679
17. B. Karlsson, S. Granberg, and M. Wikland Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - a Nordic multicenter study American Journal of Obstetrics and Gynecology 172 1995 1488 1494
18. American College of Obstetricians and Gynecologists ACOG practice bulletin, Clinical management guidelines for obstetrician-gynecologists, Number 65, August 2005: management of endometrial cancer Obstetrics and Gynecology 106 2005 413 425
19. J.K. Chan, and D.S. Kapp Role of complete lymphadenectomy in endometrioid uterine cancer Lancet Oncology 8 2007 831 841
20. ASTEC study group, H. Kitchener, and A.M. Swart Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
21. A.G. Daniel, and W.A. Peters III Accuracy of office and operating room curettage in the grading of endometrial carcinoma Gynecologic Oncology 71 1988 612 614
22. L.J. Havrilesky, J.M. Cragun, and B. Calingaert Resection of lymph node metastases influences survival in stage IIIC endometrial cancer Gynecologic Oncology 99 2005 689 695
23. M. Baekelandt, and M. Castiglione Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up Annals of Oncology 20 Suppl. 4 2009 iv29 iv31
24. E. Qvigstad, and M. Lieng Surgical treatment of endometrial cancer and atypical hyperplasia: a trend shift from laparotomy to laparoscopy Obstetrical and Gynecology International 2011 2011 829425
25. M.J. Mourits, C.B. Bijen, and H.J. Arts Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial Lancet Oncology 11 2010 763 771
26. P.C. Lim, E. Kang, and H. Park do A comparative detail analysis of the learning curve and surgical outcome for robotic hysterectomy with lymphadenectomy versus laparoscopic hysterectomy with lymphadenectomy in treatment of endometrial cancer: a case-matched controlled study of the first one hundred twenty two patients Gynecologic Oncology 120 2011 413 418
27. T. Fujimoto, J. Fukuda, and T. Tanaka Role of complete para-aortic lymphadenectomy in endometrial cancer Current Opinion in Obstetrics and Gynecology 21 2009 10 14
28. Y. Suzuki, Y. Todo, K. Okamoto, S. Minobe, and H. Kato Therapeutic impact of para-aortic lymphadenectomy in patients with high-risk, early stage and advanced stage endometrial carcinoma 2010 IGCS Prague
29. P.J. Frederick, and J.M. Straughn Jr. The role of comprehensive surgical staging in patients with endometrial cancer Cancer Control 16 2009 23 29
30. A. Mariani, M.J. Webb, L. Galli, and K.C. Podratz Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer Gynecologic Oncology 76 2000 348 356
31. Y. Todo, H. Kato, M. Kaneuchi, H. Watari, M. Takeda, and N. Sakuragi Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Lancet 375 2010 1165 1172
32. G.F. von Tempelhoff, F. Niemann, L. Heilmann, and G. Hommel Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy Clinical Hemorheology and Microcirculation 22 2000 107 130
33. W. Ageno, C. Becattini, T. Brighton, R. Selby, and P.W. Kamphuisen Cardiovascular risk factors and venous thromboembolism: a meta-analysis Circulation 117 2008 93 102
34. T. Satoh, K.K. Matsumoto, and K. Uno Silent venous thromboembolism before treatment in endometrial cancer and the risk factors British Journal of Cancer 99 2008 1034 1039
35. C.P. Klerk, S.M. Smorenburg, and H.M. Otten The effect of low molecular weight heparin on survival in patients with advanced malignancy Journal of Clinical Oncology 23 2005 2130 2135
36. M.C. Solhjem, I.A. Petersen, and M.G. Haddock Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer International Journal of Radiation Oncology, Biology, Physics 62 2005 1379 1384
37. K.M. Alektiar, E. Venkatraman, D.S. Chi, and R.R. Barakat Intravaginal brachytherapy alone for intermediate-risk endometrial cancer International Journal of Radiation Oncology, Biology, Physics 62 2005 111 117
38. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
39. H.M. Keys, J.A. Roberts, and V.L. Brunetto A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecologic Oncology 92 2004 744 751
40. C.M. Lee, A. Szabo, and D.C. Shrieve Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma JAMA 295 2006 389 397
41. N. Johnson, and P. Cornes Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis BJOG 114 2007 1313 1320
42. A. Kong, N. Johnson, and P. Cornes Adjuvant radiotherapy for stage I endometrial cancer Cochrane Database of Systematic Reviews 2007 10.1002/14651858.CD003916.pub2 Art. No. CD003916
43. R.A. Nout, H. Putter, and I.M. Jürgenliemk-Schulz Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomized PORTEC-2 trial [abstract] Journal of Clinical Oncology 26 2008 4
44. T. Hogberg, M. Signorelli, and C.F. de Oliveira Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - results from two randomised studies European Journal of Cancer 46 2010 2422 2431
45. M.E. Randall, V.L. Filiaci, and H. Muss Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study Journal of Clinical Oncology 24 2006 36 44
46. M.A. Quinn Hormonal treatment of endometrial cancer Hematology/Oncology Clinics of North America 13 1999 163 187
47. S.B. Decruze, and J.A. Green Hormone therapy in advanced and recurrent endometrial cancer: a systematic review International Journal of Gynecological Cancer 17 2007 964 978
48. A. Kauppila Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations Acta Obstetricia et Gynecologica Scandinavica 63 1984 441 450
49. D.T. Wheeler, R.E. Bristow, and R.J. Kurman Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins American Journal of Surgical Pathology 31 2007 988 998
50. F.J. Montz, R.E. Bristow, A. Bovicelli, R. Tomacruz, and R.J. Kurman Intrauterine progesterone treatment of early endometrial cancer American Journal of Obstetrics and Gynecology 186 2002 651 657
51. T.C. Randall, and R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstetrics and Gynecology 90 1997 434 440
52. T. Thigpen, M.F. Brady, and H.D. Homesley Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Journal of Clinical Oncology 19 2001 364 367
53. J.V. Fiorica, V.L. Brunetto, and P. Hanjani Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study Gynecologic Oncology 92 2004 10 14
54. C.W. Whitney, V.L. Brunetto, and R.J. Zaino Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study Gynecologic Oncology 92 2004 4 9
55. P.G. Rose, V.L. Brunetto, and L. Vanle A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study Gynecologic Oncology 78 2000 212 216
56. B.B. Ma, A. Oza, and E. Eisenhauer The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers: a study of the National Cancer Institute of Canada Clinical Trials Group International Journal of Gynecological Cancer 14 2004 650 658
57. K. Hirahatake, H. Hareyama, N. Sakuragi, M. Nishiya, S. Makinoda, and S. Fujimoto A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma Journal of Surgical Oncology 65 1997 82 87
58. J.C. Obel, G. Friberg, and G.F. Fleming Chemotherapy in endometrial cancer Clinical Advances in Hematology and Oncology 4 2006 459 468
59. W.K. Huh, J.M. Straughn Jr., and A. Mariani Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience International Journal of Gynecological Cancer 17 2007 886 889
60. C.S. Awtrey, M.G. Cadungog, and M.M. Leitao Surgical resection of recurrent endometrial carcinoma Gynecologic Oncology 102 2006 480 488
61. J.T. Thigpen, M.F. Brady, and H.D. Homesley Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study Journal of Clinical Oncology 22 2004 3902 3908
62. M.S. Aapro, F.H. van Wijk, and G. Bolis Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group Annals of Oncology 14 2003 441 448
63. B. Sorbe, H. Andersson, and K. Boman Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up International Journal of Gynecological Cancer 18 2008 803 808
64. C. Walsh, C. Holschneider, Y. Hoang, K. Tieu, B. Karlan, and I. Cass Coexisting ovarian malignancy in young women with endometrial cancer Obstetrics and Gynecology 106 2005 693 699
65. I. Grammatikakis, S. Zervoudis, N. Evangelinakis, and V. Tziortzioti Endometrium and ovarian cancer synchronous to endometriosis. A retrospective study of our experience of 7 years Journal of Medicine and Life 3 2010 76 79
66. T. Ota, M. Yoshida, M. Kimura, and K. Kinoshita Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger International Journal of Gynecological Cancer 15 2005 657 662
67. S. Topuz, I. Kalelioglu, C. Iyibozkurt, and B. Ergun Conservative management of a patient with endometrial carcinoma desiring fertility: how to inform? European Journal of Gynecological Oncology 29 2008 661 663
68. J. Boon, P.C. Scholten, A. Oldenhave, and A.P. Heintz Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT Maturitas 46 2003 69 77
69. M.K. Kim, B.S. Yoon, and H. Park Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study International Journal of Gynecological Cancer 21 2011 673 677
70. N.K. Lee, M.K. Cheung, and J.Y. Shin Prognostic factors for uterine cancer in reproductive-aged women Obstetrics and Gynecology 109 2007 655 662
71. M.M. Baekelandt, M. Castiglione, and ESMO Guidelines Working Group Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Annals of Oncology 20 Suppl. 4 2009 29 31
72. D. Denschlag, U. Ulrich, and G. Emons The diagnosis and treatment of endometrial cancer: progress and controversies Deutsches Arzteblatt International 108 2010 571 577
73. J. Wolf, and B.M. Slomovitz Novel biologic therapies for the treatment of endometrial cancer International Journal of Gynecological Cancer 15 2005 411
74. M. Oza, L. Elit, and J. Biagi Molecular correlates associated with a phase II study of temsirolimus (CCI-779) in patients with metastatic or recurrent endometrial cancer: NCIC IND 160 Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2006 24
75. V.L. Bae-Jump, C. Zhou, and J.F. Boggess The effect of rapamycin on progesterone receptor and estrogen receptor expression in endometrial cancer cells Proceedings of the Annual Meeting Society of Gynecologic Oncologists 108 2008 168
76. J.D. Wright, M.A. Powell, and J.S. Rader Bevacizumab therapy in patients with recurrent uterine neoplasms Anticancer Research 27 5B 2007 3525 3528
77. G.F. Fleming, M.A. Sill, and J.T. Thigpen Phase II evaluation of trastuzumab in patients with advanced or recurrent endometrial carcinoma: a report on GOG 181B Proceedings of the Annual Meeting of the American Society of Clinical Oncology 22 2003 453 Abstract 1821
78. K.K. Leslie, L. Laidler, and L. Albitar Tyrosine kinase inhibitors in endometrial cancer International Journal of Gynecological Cancer 15 2005 409 411